Intervacc
+FollowCoverage
- Addtech
- Alcadon
- Arise
- Avensia
- Bergs Timber
- BioGaia
- Biovica
- Boule Diagnostics
- Bredband2
- Brighter
- Briox
- Capacent
- Catella
- Catena
- Catena Media
- Cavotec
- Christian Berner Tech Trade
- Concordia Maritime
- CTT Systems
- Dedicare
- DistIT
- Diös
- Doro
- Elanders
- Electra Gruppen
- Elos Medtech
- Empir Group
- Enzymatica
- Eolus Vind
- Eurocon
- eWork
- FastPartner
- Ferronordic
- Formpipe
- Fortnox
- Future Gaming Group
- G5 Entertainment
- GARO
- Generic
- Hifab
- Hoylu
- Intervacc
- INVISIO Communications
- ITAB Shop Concept
- JLT Mobile Computers
- Lagercrantz
- Lammhults
- Leading Edge Materials
- Magnolia Bostad
- MedicaNatumin
- Midsona
- Moment Group
- Motion Display
- NAXS
- Nilörngruppen
- Nolato
- Nordic Leisure
- Nordic Waterproofing
- Opus Group
- Poolia
- Pricer
- Proact
- Probi
- QuickCool
- Railcare
- Rottneros
- Seafire
- SinterCast
- SJR
- Stendörren
- Studsvik
- Swedencare
- Swedol
- TagMaster
- Tethys Oil
- THQ Nordic
- VBG Group
- Vitec
- Vitrolife
-
Zutec
Menu
- Addtech
- Alcadon
- Arise
- Avensia
- Bergs Timber
- BioGaia
- Biovica
- Boule Diagnostics
- Bredband2
- Brighter
- Briox
- Capacent
- Catella
- Catena
- Catena Media
- Cavotec
- Christian Berner Tech Trade
- Concordia Maritime
- CTT Systems
- Dedicare
- DistIT
- Diös
- Doro
- Elanders
- Electra Gruppen
- Elos Medtech
- Empir Group
- Enzymatica
- Eolus Vind
- Eurocon
- eWork
- FastPartner
- Ferronordic
- Formpipe
- Fortnox
- Future Gaming Group
- G5 Entertainment
- GARO
- Generic
- Hifab
- Hoylu
- Intervacc
- INVISIO Communications
- ITAB Shop Concept
- JLT Mobile Computers
- Lagercrantz
- Lammhults
- Leading Edge Materials
- Magnolia Bostad
- MedicaNatumin
- Midsona
- Moment Group
- Motion Display
- NAXS
- Nilörngruppen
- Nolato
- Nordic Leisure
- Nordic Waterproofing
- Opus Group
- Poolia
- Pricer
- Proact
- Probi
- QuickCool
- Railcare
- Rottneros
- Seafire
- SinterCast
- SJR
- Stendörren
- Studsvik
- Swedencare
- Swedol
- TagMaster
- Tethys Oil
- THQ Nordic
- VBG Group
- Vitec
- Vitrolife
-
Zutec
UPCOMING EVENTS
We arrange several open investor events with our covered companies each year. Please subscribe to get information about our upcoming Introduce events.
Vaccines and pharmaceuticals for animal health
Intervacc
Intervacc is a Swedish company which develops vaccines against infectious bacteria, focused on the animal health care market. According to Intervacc’s management, the technology platform can be used to develop vaccines for any bacterial species, in principle. The company’s subsidiary, Nordvacc, distributes veterinary vaccines across the Nordic and Baltic regions, as well as in the Netherlands. Intervacc has been listed on Nasdaq First North since 2017.
The company has a strong scientific foundation underlying its revolutionary bacterial vaccine development platform. The opportunity to entry into the veterinary market, with Intervacc’s lead product Strangvac, represents a comparatively low-risk commercialisation strategy.
Regulators could demand additional data before approving the company’s lead product. Potential distribution partners may not sell Intervacc’s products as zealously as the company itself would. Competitive, regulatory, and intellectual property rights risks are significant, as with all biotech companies.
Financials
INTERVACC
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39 | N/A | N/A | 78 | 78 | 63 | 63 | 56 | 56 | 48 | 48 | 39 | 39 | 13 | 13 | 35 | 35 | ||
| Sales growth (%) | -19,4 | N/A | N/A | 0 | 0 | -19,5 | -19,5 | -11,5 | -11,5 | -13,6 | -13,6 | -19,4 | -19,4 | -67,7 | -67,7 | 180 | 180 | ||
| EBITDA | -11 | N/A | N/A | 16 | 16 | 8 | 8 | -1 | -1 | -7 | -7 | -11 | -11 | -18 | -18 | -8 | -8 | ||
| EBITDA margin (%) | -28,7 | N/A | N/A | 21 | 21 | 13,5 | 13,5 | -2 | -2 | -15 | -15 | -28,7 | -28,7 | -142,7 | -142,7 | -21,6 | -21,6 | ||
| EBIT adj | -18 | N/A | N/A | 10 | 10 | 2 | 2 | -7 | -7 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| EBIT adj margin (%) | -45,4 | N/A | N/A | 13 | 13 | 3,3 | 3,3 | -13,3 | -13,3 | -28,5 | -28,5 | -45,4 | -45,4 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| Pretax profit | -18 | N/A | N/A | 10 | 10 | 1 | 1 | -8 | -8 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| EPS rep | -0,43 | N/A | N/A | 1,16 | 1,16 | 0,01 | 0,01 | -0,61 | -0,61 | -0,79 | -0,79 | -0,43 | -0,43 | -0,65 | -0,65 | -0,41 | -0,41 | ||
| EPS growth (%) | 45,3 | N/A | N/A | 0 | 0 | -98,8 | -98,8 | -4509,8 | -4509,8 | -29,5 | -29,5 | 45,3 | 45,3 | -49,2 | -49,2 | 35,9 | 35,9 | ||
| EPS adj | -0,43 | N/A | N/A | 1,16 | 1,16 | 0,01 | 0,01 | -0,61 | -0,61 | -0,79 | -0,79 | -0,43 | -0,43 | -0,65 | -0,65 | -0,41 | -0,41 | ||
| DPS | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EV/EBITDA (x) | -20,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -14,7 | -14,7 | -20,2 | -20,2 | -14 | -14 | -35,3 | -35,3 | ||
| EV/EBIT adj (x) | -12,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -7,7 | -7,7 | -12,8 | -12,8 | -10,2 | -10,2 | -17,1 | -17,1 | ||
| P/E (x) | -17,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -9,3 | -9,3 | -17,2 | -17,2 | -11,5 | -11,5 | -18 | -18 | ||
| P/E adj (x) | -17,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -9,3 | -9,3 | -17,2 | -17,2 | -11,5 | -11,5 | -18 | -18 | ||
| EV/sales (x) | 5,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 2,2 | 2,2 | 5,8 | 5,8 | 19,9 | 19,9 | 7,6 | 7,6 | ||
| FCF yield (%) | -6,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -26,8 | -26,8 | -6,8 | -6,8 | -8,8 | -8,8 | -6,4 | -6,4 | ||
| Dividend yield (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net IB debt/EBITDA | 5 | N/A | N/A | 1,7 | 1,7 | 1,4 | 1,4 | -15,3 | -15,3 | 1,8 | 1,8 | 5 | 5 | 1,7 | 1,7 | 1,8 | 1,8 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39 | N/A | N/A | 78 | 78 | 63 | 63 | 56 | 56 | 48 | 48 | 39 | 39 | 13 | 13 | 35 | 35 | ||
| COGS | -28 | N/A | N/A | -44 | -44 | -36 | -36 | -41 | -41 | -35 | -35 | -28 | -28 | -6 | -6 | -15 | -15 | ||
| Gross profit | 10 | N/A | N/A | 34 | 34 | 27 | 27 | 15 | 15 | 13 | 13 | 10 | 10 | 6 | 6 | 20 | 20 | ||
| Other operating items | -22 | N/A | N/A | -18 | -18 | -18 | -18 | -16 | -16 | -20 | -20 | -22 | -22 | -24 | -24 | -27 | -27 | ||
| EBITDA | -11 | N/A | N/A | 16 | 16 | 8 | 8 | -1 | -1 | -7 | -7 | -11 | -11 | -18 | -18 | -8 | -8 | ||
| Depreciation on tangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation on intangibles | -6 | N/A | N/A | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -8 | -8 | ||
| EBITA | -18 | N/A | N/A | 10 | 10 | 2 | 2 | -7 | -7 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| Goodwill impairment charges | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other impairment and amortisation | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EBIT | -18 | N/A | N/A | 10 | 10 | 2 | 2 | -7 | -7 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| Other financial items | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net financial items | 0 | N/A | N/A | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Associated income | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other EO items | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Pretax profit | -18 | N/A | N/A | 10 | 10 | 1 | 1 | -8 | -8 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| Tax | 1 | N/A | N/A | 0 | 0 | -1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
| Net profit | -16 | N/A | N/A | 9 | 9 | 0 | 0 | -7 | -7 | -13 | -13 | -16 | -16 | -24 | -24 | -16 | -16 | ||
| Minority interest | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net profit discontinued | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net profit to shareholders | -16 | N/A | N/A | 9 | 9 | 0 | 0 | -7 | -7 | -13 | -13 | -16 | -16 | -24 | -24 | -16 | -16 | ||
| EPS | -0,43 | N/A | N/A | 1,16 | 1,16 | 0,01 | 0,01 | -0,61 | -0,61 | -0,79 | -0,79 | -0,43 | -0,43 | -0,65 | -0,65 | -0,41 | -0,41 | ||
| EPS Adj | -0,43 | N/A | N/A | 1,16 | 1,16 | 0,01 | 0,01 | -0,61 | -0,61 | -0,79 | -0,79 | -0,43 | -0,43 | -0,65 | -0,65 | -0,41 | -0,41 | ||
| Total extraordinary items after tax | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tax rate (%) | -7,5 | N/A | N/A | -2,9 | -2,9 | -89,4 | -89,4 | -14,3 | -14,3 | -9,6 | -9,6 | -7,5 | -7,5 | 0 | 0 | 0 | 0 | ||
| Gross margin (%) | 27 | N/A | N/A | 43,9 | 43,9 | 42,8 | 42,8 | 27,1 | 27,1 | 27 | 27 | 27 | 27 | 50 | 50 | 56,4 | 56,4 | ||
| EBITDA margin (%) | -28,7 | N/A | N/A | 21 | 21 | 13,5 | 13,5 | -2 | -2 | -15 | -15 | -28,7 | -28,7 | -142,7 | -142,7 | -21,6 | -21,6 | ||
| EBITA margin (%) | -45,4 | N/A | N/A | 13 | 13 | 3,3 | 3,3 | -13,3 | -13,3 | -28,5 | -28,5 | -45,4 | -45,4 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| EBIT margin (%) | -45,4 | N/A | N/A | 13 | 13 | 3,3 | 3,3 | -13,3 | -13,3 | -28,5 | -28,5 | -45,4 | -45,4 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| Pretax margin (%) | -45,5 | N/A | N/A | 12,3 | 12,3 | 2,1 | 2,1 | -14,3 | -14,3 | -29,4 | -29,4 | -45,5 | -45,5 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| Net margin (%) | -42,1 | N/A | N/A | 11,9 | 11,9 | 0,2 | 0,2 | -12,2 | -12,2 | -26,6 | -26,6 | -42,1 | -42,1 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| Growth rates Y/Y | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Sales growth (%) | -19,4 | N/A | N/A | 0 | 0 | -19,5 | -19,5 | -11,5 | -11,5 | -13,6 | -13,6 | -19,4 | -19,4 | -67,7 | -67,7 | 180 | 180 | ||
| EBITDA growth (%) | -54,5 | N/A | N/A | 0 | 0 | -48,3 | -48,3 | -112,9 | -112,9 | -556 | -556 | -54,5 | -54,5 | -60,7 | -60,7 | 57,6 | 57,6 | ||
| EBIT growth (%) | -28,4 | N/A | N/A | 0 | 0 | -79,4 | -79,4 | -455,4 | -455,4 | -85 | -85 | -28,4 | -28,4 | -38,4 | -38,4 | 35,9 | 35,9 | ||
| Net profit growth (%) | -27,6 | N/A | N/A | 0 | 0 | -98,5 | -98,5 | -5029,6 | -5029,6 | -87,6 | -87,6 | -27,6 | -27,6 | -49,2 | -49,2 | 35,9 | 35,9 | ||
| EPS growth (%) | 45,3 | N/A | N/A | 0 | 0 | -98,8 | -98,8 | -4509,8 | -4509,8 | -29,5 | -29,5 | 45,3 | 45,3 | -49,2 | -49,2 | 35,9 | 35,9 | ||
| Profitability | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| ROE (%) | -8,9 | N/A | N/A | 18,3 | 18,3 | 0,1 | 0,1 | -5,3 | -5,3 | -8,7 | -8,7 | -8,9 | -8,9 | -12,8 | -12,8 | -9,2 | -9,2 | ||
| ROE Adj (%) | -8,9 | N/A | N/A | 18,3 | 18,3 | 0,1 | 0,1 | -5,3 | -5,3 | -8,7 | -8,7 | -8,9 | -8,9 | -12,8 | -12,8 | -9,2 | -9,2 | ||
| ROCE (%) | -11,8 | N/A | N/A | 15,5 | 15,5 | 1,5 | 1,5 | -5,2 | -5,2 | -9,1 | -9,1 | -11,8 | -11,8 | -16,7 | -16,7 | -10,6 | -10,6 | ||
| ROCE Adj(%) | -11,8 | N/A | N/A | 15,5 | 15,5 | 1,5 | 1,5 | -5,2 | -5,2 | -9,1 | -9,1 | -11,8 | -11,8 | -16,7 | -16,7 | -10,6 | -10,6 | ||
| ROIC (%) | -10,9 | N/A | N/A | 15,1 | 15,1 | 0,2 | 0,2 | -4,4 | -4,4 | -8,3 | -8,3 | -10,9 | -10,9 | -16,7 | -16,7 | -10,6 | -10,6 | ||
| ROIC Adj (%) | -10,9 | N/A | N/A | 15,1 | 15,1 | 0,2 | 0,2 | -4,4 | -4,4 | -8,3 | -8,3 | -10,9 | -10,9 | -16,7 | -16,7 | -10,6 | -10,6 | ||
| Adj earnings numbers | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| EBITDA Adj | -11 | N/A | N/A | 16 | 16 | 8 | 8 | -1 | -1 | -7 | -7 | -11 | -11 | -18 | -18 | -8 | -8 | ||
| EBITDA Adj margin (%) | -28,7 | N/A | N/A | 21 | 21 | 13,5 | 13,5 | -2 | -2 | -15 | -15 | -28,7 | -28,7 | -142,7 | -142,7 | -21,6 | -21,6 | ||
| EBITA Adj | -18 | N/A | N/A | 10 | 10 | 2 | 2 | -7 | -7 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| EBITA Adj margin (%) | -45,4 | N/A | N/A | 13 | 13 | 3,3 | 3,3 | -13,3 | -13,3 | -28,5 | -28,5 | -45,4 | -45,4 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| EBIT Adj | -18 | N/A | N/A | 10 | 10 | 2 | 2 | -7 | -7 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| EBIT Adj margin (%) | -45,4 | N/A | N/A | 13 | 13 | 3,3 | 3,3 | -13,3 | -13,3 | -28,5 | -28,5 | -45,4 | -45,4 | -194,4 | -194,4 | -44,5 | -44,5 | ||
| Pretax profit Adj | -18 | N/A | N/A | 10 | 10 | 1 | 1 | -8 | -8 | -14 | -14 | -18 | -18 | -24 | -24 | -16 | -16 | ||
| Net profit Adj | -16 | N/A | N/A | 9 | 9 | 0 | 0 | -7 | -7 | -13 | -13 | -16 | -16 | -24 | -24 | -16 | -16 | ||
| Net profit to shareholders Adj | -16 | N/A | N/A | 9 | 9 | 0 | 0 | -7 | -7 | -13 | -13 | -16 | -16 | -24 | -24 | -16 | -16 | ||
| Net Adj margin (%) | -42,1 | N/A | N/A | 11,9 | 11,9 | 0,2 | 0,2 | -12,2 | -12,2 | -26,6 | -26,6 | -42,1 | -42,1 | -194,4 | -194,4 | -44,5 | -44,5 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | -11 | N/A | N/A | 16 | 16 | 8 | 8 | -1 | -1 | -7 | -7 | -11 | -11 | -18 | -18 | -8 | -8 | ||
| Net financial items | 0 | N/A | N/A | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Paid tax | 1 | N/A | N/A | 0 | 0 | -1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
| Non-cash items | 0 | N/A | N/A | -3 | -3 | -22 | -22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash flow before change in WC | -10 | N/A | N/A | 13 | 13 | -15 | -15 | -1 | -1 | -6 | -6 | -10 | -10 | -18 | -18 | -8 | -8 | ||
| Change in WC | 13 | N/A | N/A | -17 | -17 | -4 | -4 | -4 | -4 | 1 | 1 | 13 | 13 | 4 | 4 | -1 | -1 | ||
| Operating cash flow | -6 | N/A | N/A | -4 | -4 | -19 | -19 | -4 | -4 | -19 | -19 | -6 | -6 | -14 | -14 | -8 | -8 | ||
| CAPEX tangible fixed assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| CAPEX intangible fixed assets | -13 | N/A | N/A | -111 | -111 | -10 | -10 | -10 | -10 | -13 | -13 | -13 | -13 | -11 | -11 | -9 | -9 | ||
| Acquisitions and disposals | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Free cash flow | -19 | N/A | N/A | -115 | -115 | -30 | -30 | -15 | -15 | -32 | -32 | -19 | -19 | -25 | -25 | -18 | -18 | ||
| Dividend paid | 46 | N/A | N/A | 0 | 0 | 23 | 23 | 15 | 15 | 40 | 40 | 46 | 46 | 0 | 0 | 0 | 0 | ||
| Share issues and buybacks | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other non cash items | 16 | N/A | N/A | 86 | 86 | 23 | 23 | -6 | -6 | 21 | 21 | 16 | 16 | 0 | 0 | 0 | 0 | ||
| Decrease in net IB debt | 43 | N/A | N/A | -28 | -28 | 17 | 17 | -5 | -5 | 30 | 30 | 43 | 43 | -25 | -25 | -18 | -18 | ||
| Balance Sheet (SEKm) | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Goodwill | 132 | N/A | N/A | 111 | 111 | 115 | 115 | 120 | 120 | 127 | 127 | 132 | 132 | 135 | 135 | 135 | 135 | ||
| Indefinite intangible assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Definite intangible assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tangible fixed assets | 3 | N/A | N/A | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 5 | 5 | 6 | 6 | ||
| Other fixed assets | 7 | N/A | N/A | 4 | 4 | 4 | 4 | 3 | 3 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | ||
| Fixed assets | 142 | N/A | N/A | 118 | 118 | 122 | 122 | 126 | 126 | 135 | 135 | 142 | 142 | 147 | 147 | 148 | 148 | ||
| Inventories | 12 | N/A | N/A | 12 | 12 | 16 | 16 | 20 | 20 | 17 | 17 | 12 | 12 | 6 | 6 | 4 | 4 | ||
| Receivables | 2 | N/A | N/A | 5 | 5 | 4 | 4 | 5 | 5 | 6 | 6 | 2 | 2 | 3 | 3 | 7 | 7 | ||
| Other current assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash and liquid assets | 49 | N/A | N/A | 20 | 20 | 13 | 13 | 13 | 13 | 21 | 21 | 49 | 49 | 24 | 24 | 6 | 6 | ||
| Total assets | 205 | N/A | N/A | 155 | 155 | 155 | 155 | 164 | 164 | 180 | 180 | 205 | 205 | 179 | 179 | 165 | 165 | ||
| Shareholders equity | 202 | N/A | N/A | 102 | 102 | 127 | 127 | 130 | 130 | 165 | 165 | 202 | 202 | 177 | 177 | 162 | 162 | ||
| Minority | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total equity | 202 | N/A | N/A | 102 | 102 | 127 | 127 | 130 | 130 | 165 | 165 | 202 | 202 | 177 | 177 | 162 | 162 | ||
| Long-term debt | 0 | N/A | N/A | 53 | 53 | 28 | 28 | 33 | 33 | 15 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Pension debt | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Convertible debt | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deferred tax | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other long-term liabilities | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Short-term debt | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Accounts payable | 3 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 2 | 2 | 3 | 3 | ||
| Other current liabilities | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total liabilities and equity | 164 | N/A | N/A | 0 | 0 | 0 | 0 | 155 | 155 | 155 | 155 | 164 | 164 | 180 | 180 | 205 | 205 | ||
| Net IB debt | -56 | N/A | N/A | 28 | 28 | 12 | 12 | 17 | 17 | -13 | -13 | -56 | -56 | -31 | -31 | -13 | -13 | ||
| Net IB debt excl. pension debt | -56 | N/A | N/A | 28 | 28 | 12 | 12 | 17 | 17 | -13 | -13 | -56 | -56 | -31 | -31 | -13 | -13 | ||
| Capital invested | 146 | N/A | N/A | 131 | 131 | 138 | 138 | 147 | 147 | 152 | 152 | 146 | 146 | 146 | 146 | 148 | 148 | ||
| Working capital | 11 | N/A | N/A | 17 | 17 | 21 | 21 | 25 | 25 | 24 | 24 | 11 | 11 | 7 | 7 | 8 | 8 | ||
| EV breakdown | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Market cap. diluted (m) | 280 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 118 | 118 | 280 | 280 | 280 | 280 | 280 | 280 | ||
| Net IB debt Adj | -56 | N/A | N/A | 28 | 28 | 12 | 12 | 17 | 17 | -13 | -13 | -56 | -56 | -31 | -31 | -13 | -13 | ||
| Market value of minority | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reversal of shares and participations | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reversal of conv. debt assumed equity | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EV | 224 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 105 | 105 | 224 | 224 | 249 | 249 | 267 | 267 | ||
| Capital efficiency (%) | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Total assets turnover (%) | 20,1 | N/A | N/A | 100,8 | 100,8 | 40,6 | 40,6 | 34,9 | 34,9 | 28 | 28 | 20,1 | 20,1 | 6,5 | 6,5 | 20,4 | 20,4 | ||
| Capital invested turnover (%) | 26 | N/A | N/A | 119,6 | 119,6 | 46,8 | 46,8 | 39 | 39 | 32,1 | 32,1 | 26 | 26 | 8,6 | 8,6 | 23,8 | 23,8 | ||
| Capital employed turnover (%) | 26 | N/A | N/A | 119,6 | 119,6 | 46,8 | 46,8 | 39 | 39 | 32,1 | 32,1 | 26 | 26 | 8,6 | 8,6 | 23,8 | 23,8 | ||
| Inventories / sales (%) | 37,5 | N/A | N/A | 7,8 | 7,8 | 22,8 | 22,8 | 32,5 | 32,5 | 38,6 | 38,6 | 37,5 | 37,5 | 71,7 | 71,7 | 13,9 | 13,9 | ||
| Customer advances / sales (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Payables / sales (%) | 4,3 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,3 | 4,3 | 20,9 | 20,9 | 6,7 | 6,7 | ||
| Working capital / sales (%) | 44,1 | N/A | N/A | 10,9 | 10,9 | 29,9 | 29,9 | 40,6 | 40,6 | 50,1 | 50,1 | 44,1 | 44,1 | 69,7 | 69,7 | 20,8 | 20,8 | ||
| Financial risk and debt service | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Net debt / equity (%) | -27,8 | N/A | N/A | 27,8 | 27,8 | 9,2 | 9,2 | 12,9 | 12,9 | -7,8 | -7,8 | -27,8 | -27,8 | -17,6 | -17,6 | -8,3 | -8,3 | ||
| Net debt / market cap (%) | -20 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -10,4 | -10,4 | -20 | -20 | -11,1 | -11,1 | -4,8 | -4,8 | ||
| Equity ratio (%) | 98,4 | N/A | N/A | 66 | 66 | 81,6 | 81,6 | 79,5 | 79,5 | 91,8 | 91,8 | 98,4 | 98,4 | 99 | 99 | 98,3 | 98,3 | ||
| Net IB debt adj. / equity (%) | -27,8 | N/A | N/A | 27,8 | 27,8 | 9,2 | 9,2 | 12,9 | 12,9 | -7,8 | -7,8 | -27,8 | -27,8 | -17,6 | -17,6 | -8,3 | -8,3 | ||
| Current ratio (%) | 1859,6 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1859,6 | 1859,6 | 1735,6 | 1735,6 | 587,5 | 587,5 | ||
| EBITDA / net interest (%) | -28768,9 | N/A | N/A | 3187,1 | 3187,1 | 1084,8 | 1084,8 | -201,1 | -201,1 | -1625,7 | -1625,7 | -28768,9 | -28768,9 | 0 | 0 | 0 | 0 | ||
| Net IB debt / EBITDA (%) | 504,5 | N/A | N/A | 172,6 | 172,6 | 137,4 | 137,4 | -1533,6 | -1533,6 | 178,8 | 178,8 | 504,5 | 504,5 | 174,9 | 174,9 | 176,3 | 176,3 | ||
| Interest cover (%) | -45537,5 | N/A | N/A | 1961,9 | 1961,9 | 265,7 | 265,7 | -1358,8 | -1358,8 | -3096,9 | -3096,9 | -45537,5 | -45537,5 | 0 | 0 | 0 | 0 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018e | 2018 | 2019e | 2019 | 2020e | 2020 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares outstanding adj. | 38 | N/A | N/A | 8 | 8 | 10 | 10 | 11 | 11 | 16 | 16 | 38 | 38 | 38 | 38 | 38 | 38 | ||
| Fully diluted shares Adj | 38 | N/A | N/A | 8 | 8 | 10 | 10 | 11 | 11 | 16 | 16 | 38 | 38 | 38 | 38 | 38 | 38 | ||
| EPS | -0,43 | N/A | N/A | 1,16 | 1,16 | 0,01 | 0,01 | -0,61 | -0,61 | -0,79 | -0,79 | -0,43 | -0,43 | -0,65 | -0,65 | -0,41 | -0,41 | ||
| Dividend per share Adj | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EPS Adj | -0,43 | N/A | N/A | 1,16 | 1,16 | 0,01 | 0,01 | -0,61 | -0,61 | -0,79 | -0,79 | -0,43 | -0,43 | -0,65 | -0,65 | -0,41 | -0,41 | ||
| BVPS | 5,35 | N/A | N/A | 12,71 | 12,71 | 12,69 | 12,69 | 11,68 | 11,68 | 10,22 | 10,22 | 5,35 | 5,35 | 4,71 | 4,71 | 4,29 | 4,29 | ||
| BVPS Adj | 1,85 | N/A | N/A | -1,08 | -1,08 | 1,15 | 1,15 | 0,92 | 0,92 | 2,38 | 2,38 | 1,85 | 1,85 | 1,13 | 1,13 | 0,71 | 0,71 | ||
| Net IB debt / share | -1,5 | N/A | N/A | 3,5 | 3,5 | 1,2 | 1,2 | 1,5 | 1,5 | -0,8 | -0,8 | -1,5 | -1,5 | -0,8 | -0,8 | -0,4 | -0,4 | ||
| Share price | 7,44 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 7,62 | 7,62 | 7,44 | 7,44 | 7,44 | 7,44 | 7,44 | 7,44 | ||
| Market cap. (m) | 280 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 123 | 123 | 280 | 280 | 280 | 280 | 280 | 280 | ||
| Valuation | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| P/E | -17,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -9,3 | -9,3 | -17,2 | -17,2 | -11,5 | -11,5 | -18 | -18 | ||
| EV/sales | 5,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 2,2 | 2,2 | 5,8 | 5,8 | 19,92 | 19,92 | 7,63 | 7,63 | ||
| EV/EBITDA | -20,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -14,7 | -14,7 | -20,2 | -20,2 | -14 | -14 | -35,3 | -35,3 | ||
| EV/EBITA | -12,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -7,7 | -7,7 | -12,8 | -12,8 | -10,2 | -10,2 | -17,1 | -17,1 | ||
| EV/EBIT | -12,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -7,7 | -7,7 | -12,8 | -12,8 | -10,2 | -10,2 | -17,1 | -17,1 | ||
| Dividend yield (%) | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| FCF yield (%) | -6,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -26,8 | -26,8 | -6,8 | -6,8 | -8,8 | -8,8 | -6,4 | -6,4 | ||
| P/BVPS | 1,39 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0,72 | 0,72 | 1,39 | 1,39 | 1,58 | 1,58 | 1,73 | 1,73 | ||
| P/BVPS Adj | 4,02 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 3,09 | 3,09 | 4,02 | 4,02 | 6,57 | 6,57 | 10,48 | 10,48 | ||
| P/E Adj | -17,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -9,3 | -9,3 | -17,2 | -17,2 | -11,5 | -11,5 | -18 | -18 | ||
| EV/EBITDA Adj | -20,2 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -14,7 | -14,7 | -20,2 | -20,2 | -14 | -14 | -35,3 | -35,3 | ||
| EV/EBITA Adj | -12,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -7,7 | -7,7 | -12,8 | -12,8 | -10,2 | -10,2 | -17,1 | -17,1 | ||
| EV/EBIT Adj | -12,8 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | -7,7 | -7,7 | -12,8 | -12,8 | -10,2 | -10,2 | -17,1 | -17,1 | ||
| EV/cap. employed | 1,5 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0,7 | 0,7 | 1,5 | 1,5 | 1,7 | 1,7 | 1,8 | 1,8 | ||
| Investment ratios | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Capex / sales | 33,7 | N/A | N/A | 142 | 142 | 16,7 | 16,7 | 18,3 | 18,3 | 26,1 | 26,1 | 33,7 | 33,7 | 85 | 85 | 27 | 27 | ||
| Capex / depreciation | 201,3 | N/A | N/A | 1754,9 | 1754,9 | 163,3 | 163,3 | 161,2 | 161,2 | 192,6 | 192,6 | 201,3 | 201,3 | 164,3 | 164,3 | 118,1 | 118,1 | ||
| Capex tangibles / tangible fixed assets | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Capex intangibles / definite intangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation on intangibles / definite intangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation on tangibles / tangibles | 0 | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Company news
INTERVACC
Delårsrapport Intervacc AB januari - juni 2018
30 August 2018
Intervacc presenterar på Investerardagen 27 augusti
20 August 2018
Main shareholders
Intervacc
| Main shareholders | Share capital % | Voting shares % | Verified |
|---|---|---|---|
| K Janzon Holding AB | 10.1 % | 10.1 % | 2 Feb 2018 |
| Thomas Eklund | 8.9 % | 8.9 % | 30 Sep 2018 |
| Avanza Pension | 7.1 % | 7.1 % | 30 Sep 2018 |
| Knutsson Holdings AB | 5.6 % | 5.6 % | 30 Sep 2018 |
| Lyftet Holding BV | 5.3 % | 5.3 % | 30 Sep 2018 |
| Rothesay Ltd | 5.0 % | 5.0 % | 31 Mar 2018 |
| N.R Bergman Holding AB | 4.2 % | 4.2 % | 30 Sep 2018 |
| Fredrik Lundgren | 3.7 % | 3.7 % | 30 Sep 2018 |
| Björn Sjöstrand | 3.3 % | 3.3 % | 30 Sep 2018 |
| Nordnet Pensionsförsäkring | 3.0 % | 3.0 % | 30 Sep 2018 |
Insider list
Intervacc
| Name | Code | Quantity | Date | |
|---|---|---|---|---|
| Kenneth Jansson | -1 552 000 | GÅVA | -1 552 000 | 27 Mar 2018 |
| Kenneth Jansson | - 41 250 | GÅVA | - 41 250 | 26 Mar 2018 |
| Kenneth Jansson | - 41 250 | GÅVA | - 41 250 | 26 Mar 2018 |
QUICK FACTS
- Jan-Ingmar Flock
- Rune Bergman
- Healthcare
- www.intervacc.com
- First North
- 280,5 MSEK
- IVACC
- 29 Nov 2018
QUICK FACTS
- CEO
- Jan-Ingmar Flock
- Chairman
- Rune Bergman
- List
- First North
- Sector
- Healthcare
QUICK FACTS
- Market Cap
- 280,5 MSEK
- Ticker
- IVACC
- Next Event
- 29 Nov 2018
- Website
- www.intervacc.com
Latest articles
-
Inbjudan till Introduce Investor Day 4 december
13 Nov 2018 / Övrig artikel
-
Inbjudan till Introduce Investor Day 4 december
6 Nov 2018 / Övrig artikel
-
Intervacc - Finishing touches on the Strangles strangler
16 Oct 2018 / Analys
-
Ny kompletterande Strangvac studie påvisar immunologiskt minne under lång tid
15 Oct 2018 / Press release
-
Delårsrapport Intervacc AB januari - juni 2018
30 Aug 2018 / Press release
